Eileen Kennedy is the Georgia Athletic Association Professor at the University of Georgia (UGA), College of Pharmacy. She received her PhD from the University of California, San Diego, where she studied allosteric regulation of kinases in the department of chemistry and biochemistry. As a postdoctoral fellow in the department of chemistry and chemical biology at Harvard University, she studied the development of constrained peptide scaffolds as disruptors for protein-protein interactions. She joined the faculty of UGA in the department of pharmaceutical and biomedical sciences in 2010. Her lab focuses on the development of constrained peptides that target allosteric regulation mechanisms for kinases as they relate to disease. She has published numerous studies of the Parkinson’s disease-associated kinase, LRRK2, exploring alternative approaches for targeted inhibition as novel strategies for therapeutic development.